Contrast-induced nephropathy (CIN) is a well-known complication of therapeutic and
diagnostic procedures requiring contrast administration and accounts for 10 to 12% of acute …

Contrast induced nephropathy (CIN) is the third leading cause of hospital aquired renal
failure and is associated with significant morbidity and mortality. Chronic kidney disease is …

Contrast-induced nephropathy (CIN) is a widely recognized and clinically significant
problem in patients undergoing an increasing number of minimally invasive procedures that …

Contrast-induced nephropathy (CIN) is one of the leading causes of renal impairment in the
United States and the third cause of hospital-acquired renal failure. Reduction in the …

Contrast-induced nephropathy (CIN) is a serious, but potentially preventable adverse event
associated with the use of iodinated contrast media (CM). Studies suggest that the …

Radiological procedures utilizing intravenous iodinated contrast agents are being widely
utilized for both therapeutic and diagnostic purposes. This has resulted in an increasing …

Contrast induced nephropathy (CIN) is an iatrogenic disorder, resulting from exposure to
contrast media. Contrast‐induced hemodynamic and direct cytotoxic effects on renal …

Contrast-induced nephropathy (CIN) is a serious complication of angiographic procedures
resulting from the administration of contrast media (CM). It is the third most common cause of …

Contrast medium‐induced nephropathy (CIN) is the third leading cause of acute renal failure
in hospitalized patients. The exact mechanism by which contrast media induce renal failure …

Contrast‐induced nephropathy (CIN) is an acute and severe complication after contrast
media administration. The most important step in preventing CIN is identifying high‐risk …